Nu Skin Enterprises, Inc. (NYSE:NUS) Stock Position Increased by JPMorgan Chase & Co.

JPMorgan Chase & Co. raised its stake in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 74.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 405,667 shares of the company's stock after purchasing an additional 173,710 shares during the period. JPMorgan Chase & Co. owned 0.82% of Nu Skin Enterprises worth $2,795,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. AlphaQuest LLC raised its stake in Nu Skin Enterprises by 197.8% during the fourth quarter. AlphaQuest LLC now owns 108,204 shares of the company's stock valued at $746,000 after buying an additional 71,864 shares in the last quarter. Barclays PLC lifted its holdings in Nu Skin Enterprises by 363.8% during the 3rd quarter. Barclays PLC now owns 85,437 shares of the company's stock worth $629,000 after buying an additional 67,016 shares during the last quarter. Rhumbline Advisers lifted its holdings in Nu Skin Enterprises by 70.9% during the 4th quarter. Rhumbline Advisers now owns 138,477 shares of the company's stock worth $954,000 after buying an additional 57,443 shares during the last quarter. American Century Companies Inc. lifted its holdings in Nu Skin Enterprises by 12.0% during the 4th quarter. American Century Companies Inc. now owns 824,739 shares of the company's stock worth $5,682,000 after buying an additional 88,181 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in Nu Skin Enterprises by 18.5% during the 4th quarter. Bank of New York Mellon Corp now owns 613,330 shares of the company's stock worth $4,226,000 after buying an additional 95,938 shares during the last quarter. Institutional investors own 82.84% of the company's stock.

Nu Skin Enterprises Stock Performance

NUS stock traded up $0.07 during trading on Monday, reaching $5.84. 553,485 shares of the company's stock were exchanged, compared to its average volume of 835,709. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56. Nu Skin Enterprises, Inc. has a 1-year low of $5.32 and a 1-year high of $14.00. The company's fifty day moving average price is $7.03 and its 200-day moving average price is $6.95. The firm has a market cap of $290.38 million, a PE ratio of -1.98 and a beta of 1.10.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. The company had revenue of $445.55 million during the quarter, compared to analyst estimates of $441.10 million. On average, research analysts expect that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 5th. Stockholders of record on Monday, February 24th were paid a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a dividend yield of 4.11%. The ex-dividend date of this dividend was Monday, February 24th. Nu Skin Enterprises's dividend payout ratio is presently -8.14%.

Analyst Ratings Changes

Separately, StockNews.com downgraded Nu Skin Enterprises from a "buy" rating to a "hold" rating in a report on Tuesday, April 8th.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.